Arvind Tewari serves as the Deputy Chief Executive Officer at M42 Bahrain, bringing extensive expertise in strategy, operations, and finance across the global healthcare and life sciences sectors. Born and raised in Bahrain, he is focused on delivering world-class long-term care and rehabilitation services while supporting the Kingdom’s “Vision 2030” goals to improve healthcare quality and accessibility.
Prior to joining Amana Healthcare Bahrain, Arvind served as Vice President Strategy at Atai Life Sciences, where he led the development of digital capabilities and contributed to the company's successful Nasdaq listing, and Chief Operating Officer of OxfordVR, an Oxford University spin-out where he drove expansion into the US healthcare market. Arvind began his career in European private equity and mergers & acquisitions at Rothschild, providing him with deep insight into business growth, transformation and value creation.
Arvind holds a degree in Molecular and Cellular Biochemistry from the University of Oxford. With a focus on innovation and patient-centered care, he is dedicated to shaping advanced healthcare solutions that address Bahrain’s changing healthcare landscape.